Sopharma - Expansion mode on - 2018

Leading Bulgarian pharma group Sopharma excelled in 2017, hitting record financial results on strong exports, market expansion, M&A and synergies. With new strategic partnerships the Group is back in investment mode to match demand and further boost performance. 

Restricted Access

Please log in to your account to access the content